Amount Raised
$18.8 Million
Round Type
Series A
Investors
Description
Motif Neurotech announced a $18.75-million Series A financing round led by Arboretum Ventures with new investors KdT Ventures, Santori Capital, Dolby Family Ventures, and re.Mind Capital, as well as existing investors Divergent Capital, TMC Innovation, PsyMed Ventures, Empath Ventures, and Capital Factory participating. Amy Kruse, chief investment officer of Satori Neuro, and Tom Shehab will join its board of directors. The company plans to use the funds to advance the development of the DOT microstimulator, a wireless, battery-free device designed to be implanted in a 20-minute outpatient procedure with the capability for at-home therapy.
Quick answer
Motif Neurotech raised $18.8 Million in a Series A round, dated January 24, 2024. Investors: Satori Neuro, Capital Factory, Empath Ventures, Psy Med Ventures, TMC Innovation, Divergent Capital, Re.Mind Capital and Dolby Family Ventures. Motif Neurotech is based in Houston, Texas, United States.
- How much did Motif Neurotech raise?
- Motif Neurotech raised $18.8 Million in a Series A round on January 24, 2024.
- Who invested in Motif Neurotech?
- Satori Neuro, Capital Factory, Empath Ventures, Psy Med Ventures, TMC Innovation, Divergent Capital, Re.Mind Capital and Dolby Family Ventures are named as investors in this round.
- What does Motif Neurotech do?
- Motif Neurotech is powered by innovations in efficient wireless power and data, unlocking possibilities for new, miniature implants for tissue stimulation and diagnostic readings.
- Where is Motif Neurotech based and how big is it?
- Motif Neurotech is based in Houston, Texas, United States.
- Who are the decision-makers at Motif Neurotech?
- Fundz holds 2 contacts at Motif Neurotech, including the Chief Operating Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Medical Device around the same time
Companies in the same sectors as Motif Neurotech that raised within 45 days of this round, from Fundz verified event records.
- Biobot Surgical raised $18M (Series B) on March 7, 2024.
- Nalu Medical raised $85M (Series E) on March 6, 2024.
- Nalu Medical raised $85M (Series E) on March 5, 2024.
- Phagenesis raised $42M (Series D) on March 4, 2024.
- Gasgon Medical raised $4.3M (Seed) on February 26, 2024.
- adsilico raised $4.4M (Seed) on February 26, 2024.
Who to call at Motif Neurotech, and when
A new round usually means Motif Neurotech is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Motif Neurotech raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Motif Neurotech, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Motif Neurotech. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Motif Neurotech raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansMotif Neurotech raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.